BRUIN CLL-314: A phase 3 open label, randomized study of pirtobrutinib versus ibrutinib in patients with chronic lymphocytic leukaemia/small lymphocytic lymphoma

Jennifer ann Woyach, Catherine callaghan Coombs, Katharine l. Lewis, Maricer p. Escalon, Matteo Ceccarelli, Yuanyuan faith Bian, William g. Wierda

Research output: Contribution to journalAbstract/Meeting Abstractpeer-review

Original languageEnglish
Article numberTPS7584
JournalJournal of clinical oncology : official journal of the American Society of Clinical Oncology
Issue number16_suppl
Publication statusPublished - Jun 2023
Externally publishedYes
Event2023 ASCO Annual Meeting - Chicago, United States
Duration: 2 Jun 20236 Jun 2023

Cite this